Tin tức & Cập nhật

SARS-CoV-2 antibodies detectable in later illness stages may help diagnose COVID-19

29 Apr 2020 bởi

Immunoglobulin (Ig)M and IgG antibodies against SARS-CoV-2 can be detected in the middle and later stages of coronavirus disease 2019 (COVID-19), and an enzyme-linked immunosorbent assay (ELISA)-based antibody test demonstrates high specificity in the diagnosis of the infection, as reported in a study.

SARS-CoV-2 antibodies detectable in later illness stages may help diagnose COVID-19

29 Apr 2020

ACEIs, ARBs do not worsen COVID-19 in hypertensive patients

29 Apr 2020 bởi

Inhibitors of the renin-angiotensin system may not exacerbate the coronavirus disease 2019 (COVID-19) in patients with hypertension, according to a recent study.

ACEIs, ARBs do not worsen COVID-19 in hypertensive patients

29 Apr 2020

Leisure-time physical activity beneficial for primary cancer prevention in older adults

29 Apr 2020

Performing leisure-time physical activity (LTPA), even at lower levels than recommended, may help protect against cancer in elderly individuals, as reported in a study.

Leisure-time physical activity beneficial for primary cancer prevention in older adults

29 Apr 2020

Original New Drug Application Approvals by US FDA (16 - 30 April 2020)

29 Apr 2020

New drug applications approved by US FDA as of 16 - 30 April 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 30 April 2020)

29 Apr 2020

Low-dose aspirin may reduce HCC, liver-related death risk in chronic viral hepatitis

29 Apr 2020 bởi

The use of low-dose aspirin was associated with a significantly lower risk of incident hepatocellular carcinoma (HCC) and liver-related mortality in patients with chronic viral hepatitis compared with no aspirin use, according to a recent Swedish study.

Low-dose aspirin may reduce HCC, liver-related death risk in chronic viral hepatitis

29 Apr 2020

Dumping ACEis/ARBs over COVID-19 concern? Not so fast

28 Apr 2020 bởi

There is currently no definite evidence showing that two classes of antihypertensive medications — ACE inhibitors and ARBs* — are linked to increased risk of COVID-19 infection, leading experts say. On the contrary, what is clear is that stopping these medications simply because of concern over their perceived theoretical risk can come at a price of adverse cardiovascular (CV) events.

Dumping ACEis/ARBs over COVID-19 concern? Not so fast

28 Apr 2020

Slight elevations in uric acid may lead to excess mortality risk

28 Apr 2020

Even a slight increase in serum uric acid concentrations may increase mortality risk in the general population, a recent study has found.

Slight elevations in uric acid may lead to excess mortality risk

28 Apr 2020

Intranasal epinephrine: A potential substitute for injections?

28 Apr 2020 bởi

Three studies initially scheduled for presentation at AAAAI 2020 demonstrated that epinephrine delivered intranasally was more rapidly absorbed and led to greater haemodynamic response compared with epinephrine delivered intramuscularly.

Intranasal epinephrine: A potential substitute for injections?

28 Apr 2020

Budesonide improves dysphagia in eosinophilic oesophagitis patients

28 Apr 2020

Budesonide oral suspension appears to produce improvements in dysphagia, easing pain with swallowing, in patients with eosinophilic oesophagitis, according to a secondary analysis of a phase II trial.

Budesonide improves dysphagia in eosinophilic oesophagitis patients

28 Apr 2020

Rituximab appears to be effective in systemic rheumatoid vasculitis

28 Apr 2020

Treatment with rituximab for systemic rheumatoid vasculitis (RV) results in complete remission (CR) in 62 percent of patients and partial response (PR) in 38 percent, a study has shown.

Rituximab appears to be effective in systemic rheumatoid vasculitis

28 Apr 2020

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

SARS-CoV-2 antibodies detectable in later illness stages may help diagnose COVID-19

SARS-CoV-2 antibodies detectable in later illness stages may help diagnose COVID-19

ACEIs, ARBs do not worsen COVID-19 in hypertensive patients

ACEIs, ARBs do not worsen COVID-19 in hypertensive patients

Leisure-time physical activity beneficial for primary cancer prevention in older adults

Leisure-time physical activity beneficial for primary cancer prevention in older adults

Original New Drug Application Approvals by US FDA (16 - 30 April 2020)

Original New Drug Application Approvals by US FDA (16 - 30 April 2020)

Low-dose aspirin may reduce HCC, liver-related death risk in chronic viral hepatitis

Low-dose aspirin may reduce HCC, liver-related death risk in chronic viral hepatitis

Dumping ACEis/ARBs over COVID-19 concern? Not so fast

Dumping ACEis/ARBs over COVID-19 concern? Not so fast

Slight elevations in uric acid may lead to excess mortality risk

Slight elevations in uric acid may lead to excess mortality risk

Intranasal epinephrine: A potential substitute for injections?

Intranasal epinephrine: A potential substitute for injections?

Budesonide improves dysphagia in eosinophilic oesophagitis patients

Budesonide improves dysphagia in eosinophilic oesophagitis patients

Rituximab appears to be effective in systemic rheumatoid vasculitis

Rituximab appears to be effective in systemic rheumatoid vasculitis